In the two decades since their initial discovery, DNA vaccines technologies have come a
long way. Unfortunately, when applied to human subjects inadequate immunogenicity is still …

DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet
to become a competitive alternative to conventional protein or carbohydrate based human …

Aims With a large number of fatalities, coronavirus disease-2019 (COVID-19) has greatly
affected human health worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS …

The development of vaccines, which prime the immune system to respond to future
infections, has led to global declines in morbidity and mortality from dreadful infectious …

Infectious diseases are responsible for an overwhelming number of deaths worldwide and
their clinical management is often hampered by the emergence of multi-drug-resistant …

Annual vaccination against seasonal influenza is recommended to decrease disease-
related mortality and morbidity. However, one population that responds suboptimally to …

Vaccines, like drugs and medical procedures, are increasingly amenable to individualization
or personalization, often based on novel data resulting from high throughput “omics” …

Vaccines are public health interventions aimed at preventing infections-related mortality,
morbidity, and disability. While vaccines have been successfully designed for those …

An unprecedented increase in new vaccine development has occurred over the past three
decades. This activity has resulted in vaccines that protect against an increased range of …

The live-attenuated measles vaccine is effective, but measles outbreaks still occur in
vaccinated populations. This warrants elucidation of the determinants of measles vaccine …